Duodenal Ulcer Clinical Trial
Official title:
A Phase 3, Randomized, Double Blind, Double-Dummy, Multicenter, Parallel Group Comparison Study to on Efficacy and Safety of Oral Once-Daily Administration of TAK-438 20 mg Comparing With AG-1749 in Patients With Duodenal Ulcer
The purpose of this study is to determine the efficacy of TAK-438, once daily (QD), compared to lansoprazole in patients with duodenal ulcer.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01435525 -
Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation
|
N/A | |
| Completed |
NCT00284908 -
Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00952978 -
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)
|
Phase 3 | |
| Completed |
NCT01964131 -
BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects
|
Phase 1 | |
| Recruiting |
NCT01037491 -
Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets
|
N/A | |
| Completed |
NCT00595517 -
Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer
|
Phase 3 | |
| Completed |
NCT00953381 -
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)
|
Phase 2 | |
| Completed |
NCT05010954 -
Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer
|
Phase 3 | |
| Completed |
NCT01199536 -
Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers
|
N/A | |
| Terminated |
NCT05579444 -
Systems Biology of Gastrointestinal and Related Diseases
|
||
| Recruiting |
NCT03057171 -
A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA
|
||
| Completed |
NCT01568398 -
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy
|
Phase 3 | |
| Terminated |
NCT00762359 -
A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers
|
Phase 3 | |
| Completed |
NCT02423187 -
Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
|
||
| Completed |
NCT00543868 -
MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)
|
Phase 2 | |
| Completed |
NCT03553563 -
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer
|
Phase 3 | |
| Completed |
NCT05208268 -
A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer
|
||
| Active, not recruiting |
NCT04702542 -
To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.
|
N/A | |
| Completed |
NCT00173953 -
Lymphocytic Subsets and Cytokine Production With H. Pylori Infection
|
N/A | |
| Completed |
NCT00132171 -
Helicobacter Pylori Eradication With a New Sequential Treatment
|
Phase 3 |